lysophosphatidic acid has been researched along with Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernardi, M; Bicciato, S; Bonini, C; Casorati, G; Casucci, M; Ciceri, F; Consonni, M; de Lalla, C; De Libero, G; Dellabona, P; Garavaglia, C; Grilli, A; Häussinger, D; Mancino, A; Mastaglio, S; Montagna, D; Mori, L; Serafini, M | 1 |
| Hagiwara-Watanabe, Y; Kaneko, Y; Kasukabe, T; Niitsu, N; Okabe-Kado, J | 1 |
2 other study(ies) available for lysophosphatidic acid and Leukemia
| Article | Year |
|---|---|
Human T cells engineered with a leukemia lipid-specific TCR enables donor-unrestricted recognition of CD1c-expressing leukemia.
Topics: Animals; Antigen Presentation; Antigens, CD1; Glycoproteins; Humans; Immunotherapy, Adoptive; Leukemia; Lymphocyte Activation; Lysophospholipids; Mice; Receptors, Antigen, T-Cell; Receptors, Chimeric Antigen; T-Lymphocytes; Tissue Donors; Treatment Outcome; Xenograft Model Antitumor Assays | 2021 |
NM23 downregulation and lysophosphatidic acid receptor EDG2/lpa1 upregulation during myeloid differentiation of human leukemia cells.
Topics: Breast Neoplasms; Cell Differentiation; Down-Regulation; Female; Gene Expression Regulation, Leukemic; HL-60 Cells; Humans; K562 Cells; Leukemia; Lysophospholipids; MCF-7 Cells; Myeloid Cells; Neoplasm Proteins; NM23 Nucleoside Diphosphate Kinases; Receptors, Lysophosphatidic Acid; Tretinoin; U937 Cells; Up-Regulation | 2018 |